Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1850 of 2529 entries
View as:

Comparison of Long-term Safety of the Combination Product QVA149A Against Placebo and Standard of Care Treatment in Chronic Obstructive Pulmonary Disease Patients With Moderate to Severe Airflow Limitation

Phase: N/A Priority: Normal
NCT ID: NCT01610037 Org: User:
Start: 10/31/12 End: 02/28/15 Due: 02/28/16

Real-world Evaluation of Prevalence of Ocular Adverse Events in Patients With Neovascular (Wet) Age-related Macular Degeneration (AMD) Who Received Anti-vascular Endothelial Growth Factor (VEGF) Agents (Komodo Health)

Phase: N/A Priority: Normal
NCT ID: NCT05146687 Org: User:
Start: 07/15/20 End: 12/11/20 Due: 12/11/21

Ceritinib (LDK378) for Patients Whose Tumors Have Aberrations in ALK or ROS1 (SIGNATURE)

Phase: N/A Priority: Normal
NCT ID: NCT02186821 Org: User:
Start: 09/17/14 End: 12/13/17 Due: 12/13/18

Study of the Safety and Effectiveness of LGH447 and BYL719 in Patients With Relapsed and Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT02144038 Org: User:
Start: 07/23/14 End: 10/28/15 Due: 10/28/16

Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Elderly Patients With Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01615198 Org: User:
Start: 08/31/12 End: 07/31/13 Due: 07/31/14

Study Assessing the Efficacy and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced TNBC Who Carry Either a PIK3CA Mutation or Have PTEN Loss

Phase: N/A Priority: Normal
NCT ID: NCT04251533 Org: User:
Start: 06/08/20 End: 09/05/25 Due: 09/05/26

Platform Study of Novel Ruxolitinib Combinations in Myelofibrosis Patients

Phase: N/A Priority: Normal
NCT ID: NCT04097821 Org: User:
Start: 09/26/19 End: 08/28/24 Due: 08/28/25

A Survey to Evaluate Early Experience From Patient and Care Partner on Injection and Device for KESIMPTA® Indicated for Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT05334472 Org: User:
Start: 11/24/21 End: 02/15/23 Due: 02/15/24

Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy

Phase: N/A Priority: Normal
NCT ID: NCT01316458 Org: User:
Start: 06/30/03 End: - Due: -

Open Label Study of a Single Dose of a New Extended Long Acting Formulation of Octreotide Pamoate in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00432068 Org: User:
Start: 01/31/07 End: 06/30/10 Due: 06/30/11

Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonists

Phase: N/A Priority: Normal
NCT ID: NCT00670930 Org: User:
Start: 04/30/08 End: 11/30/11 Due: 11/30/12

Safety, Tolerability, and Efficacy Study of CLL442 in Patients With Cutaneous Squamous Cell Carcinoma in Situ (SCCis)

Phase: N/A Priority: Normal
NCT ID: NCT03333694 Org: User:
Start: 12/15/17 End: 11/01/18 Due: 11/01/19

Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients

Phase: N/A Priority: Normal
NCT ID: NCT04578834 Org: User:
Start: 01/25/21 End: 10/02/25 Due: 10/02/26

Efficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension Phase

Phase: N/A Priority: Normal
NCT ID: NCT00991146 Org: User:
Start: 10/31/09 End: 02/29/12 Due: 02/28/13

Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01132664 Org: User:
Start: 05/31/10 End: 08/31/14 Due: 08/31/15

Efficacy and Safety of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00099268 Org: User:
Start: 09/30/04 End: 11/30/08 Due: 11/30/09

Migraine Survey in Gulf Region

Phase: N/A Priority: Normal
NCT ID: NCT06237062 Org: User:
Start: 06/05/24 End: 03/30/25 Due: 03/30/26

Safety and Efficacy of VAY736 in Patients With Primary Sjogren's Syndrome (pSS)

Phase: N/A Priority: Normal
NCT ID: NCT02962895 Org: User:
Start: 06/27/17 End: 09/23/21 Due: 09/23/22

An Extension Study to Determine the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Participants With Ph+ Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00171249 Org: User:
Start: 08/09/99 End: 09/23/13 Due: 09/23/14

Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00719264 Org: User:
Start: 11/12/08 End: 04/15/13 Due: 04/15/14

Safety of Tobramycin Inhalation Powder (TIP) vs Tobramycin Solution for Inhalation in Patients With Cystic Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT00388505 Org: User:
Start: 02/28/06 End: 03/31/09 Due: 03/31/10

Safety Study of LLF580 in Obese Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03466203 Org: User:
Start: 02/26/18 End: 11/13/19 Due: 11/13/20

Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT01892722 Org: User:
Start: 07/26/13 End: 02/18/30 Due: 02/18/31

Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients

Phase: N/A Priority: Normal
NCT ID: NCT03814746 Org: User:
Start: 07/26/19 End: 12/14/26 Due: 12/14/27

Open-label Study of Subcutaneous Secukinumab to Evaluate Efficacy and Safety in Patients With Plaque Psoriasis Who Had Inadequate Response to Cyclosporine A

Phase: N/A Priority: Normal
NCT ID: NCT02547714 Org: User:
Start: 06/16/15 End: 05/02/16 Due: 05/02/17